Rett Syndrome Research Trust Awards $5.8 Million to Advance the Development of Treatments and Cures for Rett Syndrome and MECP2 Disorders

Rett Syndrome Research Trust Awards $5.8 Million to Advance the Development of Treatments and Cures for Rett Syndrome and MECP2 Disorders
Trumbull, CT (PRWEB) February 03, 2015 Today the Rett Syndrome Research Trust (RSRT) announced research investments of $ 5.8 million awarded in 2014. RSRT’s sole and urgent goal is to abolish Rett Syndrome and related disorders. To that end, RSRT has awarded $ 25 million to research since its launch in 2008. Rett Syndrome ...

Neuren Announces Results of the NNZ-2566 Clinical Trial for Rett Syndrome

Cincinnati, Ohio (PRWEB) November 11, 2014 Neuren Pharmaceuticals’ human clinical trial using NNZ-2566 as a potential treatment for Rett syndrome (a trial supported by Rettsyndrome.org) was completed in September of this year. On November 11, Neuren announced the results of this phase 2 placebo-controlled study, which investigated the dosing of NNZ-2566 for safety and tolerability ...